U.S. Life Sciences Stock News

ZORYVE (roflumilast) cream has received a strong, high certainty recommendation in the American Academy of Dermatology’s new pediatric atopic dermatitis guidelines. This is the AAD’s first set of clinical practice guidelines focused on pediatric atopic dermatitis, giving the product formal visibility in a key treatment area. The endorsement supports ZORYVE’s role as an evidence backed option for long term use in children with atopic dermatitis. For Arcutis Biotherapeutics (NasdaqGS:ARQT),...

Heartland Express (HTLD) opened 2026 with Q1 results that extend a run of soft profitability, capped by trailing 12 month revenue of US$805.7 million and a basic EPS loss of US$0.67 tied to a net loss of US$52.5 million. Over the past six reported quarters, quarterly revenue has ranged from US$179.4 million to US$259.9 million, while basic EPS has moved between a loss of US$0.02 and a loss of US$0.25. This sets up a story where investors are weighing ongoing losses against forecasts that...

Martin Midstream Partners (MMLP) opened 2026 with Q1 results that keep the focus squarely on profitability, as the latest trailing 12 month figures show total revenue of US$716.1 million and a loss of US$14.4 million, or basic EPS of US$0.37. Over recent quarters, the partnership has seen quarterly revenue range from US$168.7 million to US$192.5 million, while basic EPS has moved between a profit of US$0.09 and losses of up to US$0.21. This sets up an earnings release where investors are...

Popular (BPOP) has just posted another solid quarter, with Q4 2025 revenue of US$751.8 million and basic EPS of US$3.54, setting the tone as investors look at the new Q1 2026 reporting period. The bank has seen quarterly revenue move from US$689.4 million in Q4 2024 to US$751.8 million in Q4 2025, while basic EPS over that same stretch climbed from US$2.51 to US$3.54, giving you a clear sense of how the income line has scaled alongside the top line. Taken together with an improved net profit...

Katahdin Bankshares (KTHN) has just put another quarter on the board, with Q4 2025 revenue of US$11.9 million and basic EPS of US$0.99 setting the tone after a year in which trailing net income reached US$10.7 million on revenue of US$44.3 million. Over recent periods the company has seen revenue move from US$9.5 million and EPS of roughly US$0.56 in Q4 2024 to US$11.9 million and US$0.99 respectively in Q4 2025. Trailing basic EPS for the last reported twelve months reached about US$3.37...

American Riviera Bancorp (ARBV) opened 2026 with Q1 results that build on a solid finish to last year, with Q4 2025 revenue at about US$14.4 million and basic EPS of roughly US$0.80, while trailing twelve month revenue stood at about US$50.4 million and EPS at roughly US$2.18. Over recent quarters, revenue has moved from about US$10.7 million in Q4 2024 to US$14.4 million in Q4 2025, and basic EPS has shifted from roughly US$0.35 to US$0.80. This sets up a story where higher net income and...

Medpace Holdings (MEDP) has followed up its recent run of strong results with Q4 2025 revenue of US$708.5 million and basic EPS of US$4.78, backing that up with trailing 12 month revenue of about US$2.5 billion and EPS of US$15.64. Over recent quarters the company has seen revenue move from US$533.3 million in Q3 2024 to US$708.5 million in Q4 2025, while quarterly basic EPS has ranged from US$3.11 to US$4.78 across the same stretch. With trailing net profit margins at 17.8% versus 19.2% the...

Mesabi Trust (MSB) has put fresh FY 2026 numbers on the table, with third quarter revenue of US$3.6 million, basic EPS of US$0.21 and net income of US$2.8 million. The trust has seen quarterly revenue move between US$4.7 million and US$6.9 million and EPS range from US$0.28 to US$0.46 over the past year of reported periods, alongside net income between US$3.6 million and US$6.1 million. This sets a clear context for the latest print. With a trailing net margin of 82.8% and earnings quality...

Farmers & Merchants Bancorp (FMAO) has put fresh numbers on the board, with Q4 2025 revenue of about US$31.9 million and basic EPS of US$0.70, supported by net income of US$9.7 million as the latest marker ahead of its Q1 2026 reporting period. The business has seen revenue move from US$26.6 million and EPS of US$0.59 in Q4 2024 to US$31.9 million and EPS of US$0.70 in Q4 2025. Trailing 12 month earnings growth of 29.4% and a 27.6% net margin frame a profitability profile that many investors...

Southern Missouri Bancorp (SMBC) opened Q3 2026 with Q2 results that put revenue and earnings in clear focus, reporting total revenue of US$48.0 million and basic EPS of US$1.62 on net income of US$18.1 million. The company has seen revenue move from US$41.7 million with EPS of US$1.10 in Q1 2025 to US$45.1 million and EPS of US$1.40 in Q4 2025, then to US$48.0 million and EPS of US$1.62 in Q2 2026. This latest report can be viewed as part of a steady earnings story that investors can now...

Thermo Fisher Scientific (TMO) has just put fresh numbers on the table, with Q4 2025 revenue of US$12.2b and basic EPS of US$5.22 setting the tone against a trailing twelve month EPS of US$17.78 on revenue of US$44.6b, alongside net income of US$6.7b. The company has seen quarterly revenue move from US$10.6b in Q3 2024 to US$12.2b in Q4 2025, while basic EPS over the same period went from US$4.27 to US$5.22. This gives investors a clear read on top line scale and earnings power as they assess...

Kearny Financial (KRNY) has just reported Q3 2026 results with quarterly revenue in the low US$40 million range and basic EPS of about US$0.15, set against a trailing twelve month EPS of US$0.52 that reflects the shift back into profitability. Over recent periods, revenue has moved from US$36.96 million in Q1 2025 to US$42.97 million in Q2 2026, while quarterly EPS has stepped from roughly US$0.10 to just over US$0.15. This gives investors a clearer read on how earnings now sit relative to...

First Bancorp (FBNC) opened 2026 with Q1 results that put the focus squarely on the income statement, reporting total revenue of US$119.2 million and basic EPS of US$1.13, backed by trailing twelve month revenue of US$393.3 million and EPS of US$2.93. Over recent periods the company has seen quarterly revenue move from US$65.2 million in Q4 2024 to US$104.7 million in Q1 2025, US$108.8 million in Q2, US$86.2 million in Q3 and US$79.2 million in Q4, while EPS shifted from US$0.09 to US$0.88,...

Dover (DOV) kicked off Q1 2026 against a backdrop of recent quarterly revenue between US$1.87 billion and US$2.10 billion and basic EPS ranging from US$1.74 to US$2.21 through 2025, with trailing 12 month revenue at about US$8.09 billion and EPS at US$8.01. Over that same trailing period, revenue has stayed in a tight band around US$7.72 billion to US$8.09 billion, while EPS moved between US$7.55 and US$8.01. This provides a clear sense of how top line and per share earnings have been...

CSX (CSX) has just opened its 2026 reporting year with investors still focused on the recent Q4 2025 numbers, where revenue came in at US$3.5b and basic EPS was US$0.39, setting the reference point for how Q1 performance will be judged. Over the past few quarters, revenue has held in a tight band around US$3.4b to US$3.6b, while basic EPS moved between US$0.34 and US$0.44, giving a clear read on how small shifts in volumes and pricing flow through to earnings. With trailing net margins at...

QCR Holdings (QCRH) just wrapped up Q1 2026 with recent quarterly revenue running around US$101.5 million and basic EPS of about US$2.13, backed by trailing twelve month revenue of roughly US$351.5 million and EPS of US$7.54 that has been associated with an 11.7% earnings growth rate over the past year. Over recent periods, the company has seen revenue move from US$330.2 million and EPS of US$6.77 on a trailing basis in Q4 2024 to US$351.5 million and EPS of US$7.54 by Q4 2025, supported by a...

CVB Financial (CVBF) opened 2026 with Q1 numbers that keep the focus squarely on profitability, with trailing 12 month EPS at US$1.52 on total revenue of US$518.96 million and net income of US$207.92 million. The company has seen revenue move from US$504.82 million to US$518.96 million over the past year, while trailing EPS shifted from US$1.44 to US$1.52, setting up this quarter against a backdrop of slightly higher margins and earnings. See our full analysis for CVB Financial. With the...

WillScot Holdings (NasdaqCM:WSC) has been certified as a Great Place to Work® for the fourth consecutive year. The recognition is based on employee feedback about workplace culture, safety, and support. This ongoing certification highlights WillScot's focus on employee engagement and organizational health. WillScot, which provides modular space and portable storage solutions, is operating in an industry where execution, safety, and on site reliability matter to customers. A consistent Great...

Gentherm (THRM) has opened Q1 2026 earnings season with recent quarterly numbers that show total revenue at about US$382.8 million in Q4 2025 and basic EPS of roughly US$0.10, following earlier quarters that ranged from a small loss to stronger profitability. Over the last six reported quarters, revenue has moved between US$352.9 million and US$386.9 million while basic EPS has ranged from a small loss of roughly US$0.00 per share in early 2025 to about US$0.51 per share in several 2024 and...

PG&E (PCG) has kicked off Q1 2026 with recent quarterly revenue of about US$6.8 billion and basic EPS of US$0.29, set against a trailing twelve month EPS of US$1.18 and net income of US$2.6 billion. Together, these figures frame the scale of its earnings power. Over recent quarters, revenue has moved from US$6.0 billion in Q1 2025 to US$6.3 billion in Q3 and US$6.8 billion in Q4, while quarterly EPS has ranged between US$0.24 and US$0.37 over that stretch. This gives investors a clear view of...

Stewart Information Services (STC) opened 2026 with Q1 revenue of US$781.3 million and basic EPS of US$0.55, against a backdrop of trailing twelve month revenue of about US$3.1 billion and EPS of US$4.51 that reflects the recent ramp up in profitability. Over the past year, the company has seen revenue move from US$2.55 billion on a trailing basis to roughly US$3.10 billion, while trailing EPS stepped up from US$2.64 to US$4.51. This sets the stage for investors to weigh improving margins and...

Esquire Financial Holdings (ESQ) opened the year with Q4 2025 revenue of US$36.5 million and basic EPS of US$1.66, setting the backdrop for how you might read the upcoming Q1 2026 release. The company reported revenue of US$31.4 million and EPS of US$1.49 in Q4 2024 and US$36.5 million and EPS of US$1.66 in Q4 2025, giving you a clear view of how the top line and EPS have tracked over the last year as you judge the latest update. With these figures in hand, the focus naturally turns to how...

First Industrial Realty Trust (FR) opened 2026 with Q1 funds from operations of US$92.5 million, or US$0.68 per share, setting the tone for how its industrial portfolio is feeding through to cash based earnings. Over recent quarters, the company has seen total revenue move from US$175.3 million in Q4 2024 to US$188.8 million in Q4 2025, while basic EPS over that same period went from US$0.52 to US$0.59, giving investors a clearer view of how top line growth is filtering into the bottom line...

Boston Scientific (BSX) opened 2026 with Q1 revenue of US$5.2b and basic EPS of US$0.90, alongside trailing 12 month EPS of US$2.41 on revenue of US$20.6b that sits against a 75.4% jump in earnings over the past year. Over recent quarters the company has seen revenue move from US$4.7b in Q1 2025 to around US$5.2b in Q1 2026, while quarterly EPS has ranged from roughly US$0.46 to US$0.90. This sets up a picture of expanding profitability supported by a higher net margin. See our full analysis...